2011 Q2 Form 10-Q Financial Statement

#000140549511000008 Filed on July 29, 2011

View on sec.gov

Income Statement

Concept 2011 Q2 2010 Q2
Revenue $69.87M $91.15M
YoY Change -23.35% 21.7%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.547M $7.008M
YoY Change 7.69% -67.56%
% of Gross Profit
Research & Development $15.76M $16.36M
YoY Change -3.67% 23.97%
% of Gross Profit
Depreciation & Amortization $6.000M $5.300M
YoY Change 13.21% 12.77%
% of Gross Profit
Operating Expenses $23.31M $23.37M
YoY Change -0.27% -32.84%
Operating Profit $29.81M $53.07M
YoY Change -43.84%
Interest Expense -$3.100M $500.0K
YoY Change -720.0%
% of Operating Profit -10.4% 0.94%
Other Income/Expense, Net -$300.0K $400.0K
YoY Change -175.0% -33.33%
Pretax Income $26.43M $53.96M
YoY Change -51.03% 31.94%
Income Tax $9.270M $19.00M
% Of Pretax Income 35.08% 35.21%
Net Earnings $17.16M $34.96M
YoY Change -50.93% 32.44%
Net Earnings / Revenue 24.55% 38.36%
Basic Earnings Per Share $0.38 $0.80
Diluted Earnings Per Share $0.37 $0.78
COMMON SHARES
Basic Shares Outstanding 45.37M shares 43.97M shares
Diluted Shares Outstanding 45.84M shares 44.71M shares

Balance Sheet

Concept 2011 Q2 2010 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $701.1M $485.8M
YoY Change 44.32% 124.28%
Cash & Equivalents $379.6M $217.4M
Short-Term Investments $321.5M $268.4M
Other Short-Term Assets $62.70M $78.30M
YoY Change -19.92% -4.98%
Inventory
Prepaid Expenses
Receivables $29.70M $159.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $793.5M $723.2M
YoY Change 9.71% 33.06%
LONG-TERM ASSETS
Property, Plant & Equipment $7.609M $9.300M
YoY Change -18.18% -13.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $47.90M $86.50M
YoY Change -44.62% 118.43%
Total Long-Term Assets $246.6M $221.5M
YoY Change 11.32% 38.78%
TOTAL ASSETS
Total Short-Term Assets $793.5M $723.2M
Total Long-Term Assets $246.6M $221.5M
Total Assets $1.040B $944.7M
YoY Change 10.09% 34.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.300M $9.300M
YoY Change -43.01% 19.23%
Accrued Expenses $17.90M $21.80M
YoY Change -17.89% 27.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $301.0K $300.0K
YoY Change 0.33% -50.0%
Total Short-Term Liabilities $164.8M $252.5M
YoY Change -34.74% 7.08%
LONG-TERM LIABILITIES
Long-Term Debt $188.8M $300.0K
YoY Change 62833.33% -66.67%
Other Long-Term Liabilities $14.23M $426.4M
YoY Change -96.66% 15.9%
Total Long-Term Liabilities $14.23M $426.7M
YoY Change -96.67% 15.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $164.8M $252.5M
Total Long-Term Liabilities $14.23M $426.7M
Total Liabilities $618.4M $679.2M
YoY Change -8.95% 12.34%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $569.2M
YoY Change
Treasury Stock Shares 23.57M shares 23.57M shares
Shareholders Equity $421.6M $265.5M
YoY Change
Total Liabilities & Shareholders Equity $1.040B $944.7M
YoY Change 10.09% 34.36%

Cashflow Statement

Concept 2011 Q2 2010 Q2
OPERATING ACTIVITIES
Net Income $17.16M $34.96M
YoY Change -50.93% 32.44%
Depreciation, Depletion And Amortization $6.000M $5.300M
YoY Change 13.21% 12.77%
Cash From Operating Activities -$26.10M $8.800M
YoY Change -396.59% -83.17%
INVESTING ACTIVITIES
Capital Expenditures -$7.400M -$7.700M
YoY Change -3.9% -13.48%
Acquisitions
YoY Change
Other Investing Activities $6.000M -$300.0K
YoY Change -2100.0% -98.14%
Cash From Investing Activities -$1.400M -$8.000M
YoY Change -82.5% -68.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 206.9M 2.200M
YoY Change 9304.55% -117.19%
NET CHANGE
Cash From Operating Activities -26.10M 8.800M
Cash From Investing Activities -1.400M -8.000M
Cash From Financing Activities 206.9M 2.200M
Net Change In Cash 179.4M 3.000M
YoY Change 5880.0% -79.31%
FREE CASH FLOW
Cash From Operating Activities -$26.10M $8.800M
Capital Expenditures -$7.400M -$7.700M
Free Cash Flow -$18.70M $16.50M
YoY Change -213.33% -73.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
7572000 USD
CY2011Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
5326000 USD
CY2010Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
33632000 USD
CY2011Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
29734000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1834000 USD
us-gaap Accretion Of Discount
AccretionOfDiscount
1834000 USD
CY2011Q2 us-gaap Accretion Of Discount
AccretionOfDiscount
1834000 USD
CY2011Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
44000 USD
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
111000 USD
CY2010Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
217431000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
210863000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
164138000 USD
CY2011Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
563128000 USD
CY2010Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
525767000 USD
CY2011Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1750000 USD
CY2010Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1750000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
326000 USD
CY2011Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
326000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2010Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2011Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2011Q2 us-gaap Assets
Assets
1040022000 USD
CY2010Q4 us-gaap Assets
Assets
874643000 USD
CY2010Q4 us-gaap Assets Current
AssetsCurrent
619556000 USD
CY2011Q2 us-gaap Assets Current
AssetsCurrent
793451000 USD
CY2010Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
255087000 USD
CY2011Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
246571000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
215451000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
379589000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6568000 USD
CY2011Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3500000 shares
CY2011Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
500000 shares
CY2011Q2 us-gaap Commercial Paper
CommercialPaper
12000000 USD
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2010Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.00
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.00
CY2011Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2010Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2010Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68968000 shares
CY2010Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68602000 shares
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45398000 shares
CY2010Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45032000 shares
CY2010Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
686000 USD
CY2011Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
689000 USD
CY2010Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
35030000 USD
CY2011Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17077000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
83830000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40428000 USD
CY2011Q2 us-gaap Concentration Risk Additional Characteristic
ConcentrationRiskAdditionalCharacteristic
three
CY2010Q2 us-gaap Concentration Risk Additional Characteristic
ConcentrationRiskAdditionalCharacteristic
four
CY2010Q2 us-gaap Concentration Risk Percentage
ConcentrationRiskPercentage
0.92
CY2011Q2 us-gaap Concentration Risk Percentage
ConcentrationRiskPercentage
0.91
us-gaap Costs And Expenses
CostsAndExpenses
81218000 USD
us-gaap Costs And Expenses
CostsAndExpenses
79585000 USD
CY2011Q2 us-gaap Costs And Expenses
CostsAndExpenses
40066000 USD
CY2010Q2 us-gaap Costs And Expenses
CostsAndExpenses
38079000 USD
CY2011Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.07
CY2011Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
41204000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1823000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7360000 USD
CY2010Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
134804000 USD
CY2011Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
132962000 USD
CY2011Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
250551000 USD
CY2010Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
332174000 USD
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
-118934000 USD
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
-133643000 USD
CY2011Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
51754000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
35136000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
71754000 USD
CY2011Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
56959000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10803000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11751000 USD
CY2011Q1 us-gaap Derivative Price Risk Option Strike Price
DerivativePriceRiskOptionStrikePrice
66.3528
CY2010Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4526000 USD
CY2011Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4540000 USD
CY2010Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.88
CY2010Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.355
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.352
CY2010Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22933000 USD
CY2011Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9231000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1342000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
681000 USD
CY2011Q2 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
22000000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
1616000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
62790000 USD
CY2010Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
53963000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
26426000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
129244000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45454000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22295000 USD
CY2010Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9270000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1703000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2104000 USD
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
17407000 USD
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-51000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2530000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-173000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
52497000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
35469000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2784000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-10231000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1686000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3872000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
661000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1169000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3898000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-53819000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
1438000 USD
CY2011Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1438000 USD
CY2010Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
889000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1489000 USD
CY2011Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
-3381000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
-4323000 USD
CY2011Q2 us-gaap Liabilities
Liabilities
618381000 USD
CY2010Q4 us-gaap Liabilities
Liabilities
521527000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
874643000 USD
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1040022000 USD
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
178560000 USD
CY2011Q2 us-gaap Liabilities Current
LiabilitiesCurrent
164780000 USD
CY2011Q2 us-gaap Long Term Debt
LongTermDebt
188822000 USD
CY2010Q4 us-gaap Long Term Debt
LongTermDebt
180000 USD
CY2011Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
301000 USD
CY2010Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
288000 USD
CY2011Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
240600000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
205490000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9373000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84353000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10095000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31257000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81548000 USD
CY2010Q2 us-gaap Net Income Loss
NetIncomeLoss
34963000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
17156000 USD
us-gaap Net Income Loss
NetIncomeLoss
83790000 USD
us-gaap Net Income Loss
NetIncomeLoss
40495000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
83790000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
40495000 USD
CY2010Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
34963000 USD
CY2011Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17156000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
40495000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
83790000 USD
CY2010Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
34963000 USD
CY2011Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
17156000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
67113000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
29807000 USD
CY2010Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
53074000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
127755000 USD
CY2010Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
4762000 USD
CY2011Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
8634000 USD
CY2010Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44684000 USD
CY2011Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
47904000 USD
CY2011Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14228000 USD
CY2010Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10613000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
161000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-254000 USD
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
42665000 USD
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8015000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
9062000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1088000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
240151000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1826000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
362285000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
309548000 USD
CY2010Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2011Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2011Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
14399000 shares
CY2010Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
14399000 shares
CY2011Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2010Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2010Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2010Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2011Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2011Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10850000 USD
CY2010Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9119000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
31740000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
230000000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
367142000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2952000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8465000 USD
CY2011Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7609000 USD
CY2010Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8344000 USD
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
434000 USD
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
141000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32528000 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15763000 USD
CY2010Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16364000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33187000 USD
CY2010Q4 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
395799000 USD
CY2011Q2 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
427027000 USD
CY2010Q2 us-gaap Revenues
Revenues
91153000 USD
us-gaap Revenues
Revenues
148331000 USD
us-gaap Revenues
Revenues
207340000 USD
CY2011Q2 us-gaap Revenues
Revenues
69873000 USD
CY2010Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
3675000 USD
CY2011Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
3786000 USD
CY2010Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
23570000 shares
CY2011Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
23570000 shares
CY2011Q2 us-gaap Treasury Stock Value
TreasuryStockValue
569247000 USD
CY2010Q4 us-gaap Treasury Stock Value
TreasuryStockValue
569247000 USD
CY2011Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-79000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14527000 USD
CY2010Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7008000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15327000 USD
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7547000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3367000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2634000 USD
CY2010Q4 us-gaap Short Term Investments
ShortTermInvestments
326218000 USD
CY2011Q2 us-gaap Short Term Investments
ShortTermInvestments
321524000 USD
us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
100000000 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
421641000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
353116000 USD
CY2011Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
990888000 USD
CY2010Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
922363000 USD
CY2010Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
67000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
40000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-67000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
752000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
520000 shares
CY2010Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
735000 shares
CY2011Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
474000 shares
CY2010Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44706000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44546000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45858000 shares
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45843000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43794000 shares
CY2010Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43971000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45338000 shares
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45369000 shares
idcc Capitalized Patent Costs
CapitalizedPatentCosts
13868000 USD
idcc Capitalized Patent Costs
CapitalizedPatentCosts
13126000 USD
idcc Dilutive Securitie Effect On Basic Earnings Per Share
DilutiveSecuritieEffectOnBasicEarningsPerShare
-0.01 USD
idcc Dilutive Securitie Effect On Basic Earnings Per Share
DilutiveSecuritieEffectOnBasicEarningsPerShare
-0.03 USD
CY2010Q2 idcc Dilutive Securitie Effect On Basic Earnings Per Share
DilutiveSecuritieEffectOnBasicEarningsPerShare
-0.02 USD
CY2011Q2 idcc Dilutive Securitie Effect On Basic Earnings Per Share
DilutiveSecuritieEffectOnBasicEarningsPerShare
-0.01 USD
CY2011Q2 idcc Finite Lived Patents Net
FiniteLivedPatentsNet
134099000 USD
CY2010Q4 idcc Finite Lived Patents Net
FiniteLivedPatentsNet
130305000 USD
CY2010 idcc Foreign Withholding Taxes Accrued
ForeignWithholdingTaxesAccrued
2900000 USD
idcc Foreign Witholding Taxes Paid
ForeignWitholdingTaxesPaid
16500000 USD
idcc Foreign Witholding Taxes Paid
ForeignWitholdingTaxesPaid
4800000 USD
CY2011Q2 idcc Patent Administration And Licensing
PatentAdministrationAndLicensing
16756000 USD
idcc Patent Administration And Licensing
PatentAdministrationAndLicensing
32704000 USD
idcc Patent Administration And Licensing
PatentAdministrationAndLicensing
32530000 USD
CY2010Q2 idcc Patent Administration And Licensing
PatentAdministrationAndLicensing
14707000 USD
idcc Senior Convertible Note Note Hedge And Warrant Transaction Interest Expense
SeniorConvertibleNoteNoteHedgeAndWarrantTransactionInterestExpense
3598000 USD
CY2011Q2 idcc Senior Convertible Note Note Hedge And Warrant Transaction Interest Expense
SeniorConvertibleNoteNoteHedgeAndWarrantTransactionInterestExpense
3598000 USD
CY2011Q2 idcc Senior Convertible Notes Net Of Unamortized Discount
SeniorConvertibleNotesNetOfUnamortizedDiscount
188796000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
dei Document Period End Date
DocumentPeriodEndDate
2011-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001405495
CY2011Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45443946 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
INTERDIGITAL, INC.

Files In Submission

Name View Source Status
0001405495-11-000008-index-headers.html Edgar Link pending
0001405495-11-000008-index.html Edgar Link pending
0001405495-11-000008.txt Edgar Link pending
0001405495-11-000008-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
idcc-20110630.xml Edgar Link completed
idcc-20110630.xsd Edgar Link pending
idcc-20110630_cal.xml Edgar Link unprocessable
idcc-20110630_def.xml Edgar Link unprocessable
idcc-20110630_lab.xml Edgar Link unprocessable
idcc-20110630_pre.xml Edgar Link unprocessable
idcc-2011630x10qxq2.htm Edgar Link pending
idcc-2011630x10qxq2ex311.htm Edgar Link pending
idcc-2011630x10qxq2ex312.htm Edgar Link pending
idcc-2011630x10qxq2ex321.htm Edgar Link pending
idcc-2011630x10qxq2ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending